Literature DB >> 32594794

Machine Learning Clustering for Blood Pressure Variability Applied to Systolic Blood Pressure Intervention Trial (SPRINT) and the Hong Kong Community Cohort.

Kelvin K F Tsoi1,2, Nicholas B Chan1, Karen K L Yiu2, Simon K S Poon3, Bryant Lin4, Kendall Ho5.   

Abstract

Visit-to-visit blood pressure variability (BPV) has been shown to be a predictor of cardiovascular disease. We aimed to classify the BPV levels using different machine learning algorithms. Visit-to-visit blood pressure readings were extracted from the SPRINT study in the United States and eHealth cohort in Hong Kong (HK cohort). Patients were clustered into low, medium, and high BPV levels with the traditional quantile clustering and 5 machine learning algorithms including K-means. Clustering methods were assessed by Stability Index. Similarities were assessed by Davies-Bouldin Index and Silhouette Index. Cox proportional hazard regression models were fitted to compare the risk of myocardial infarction, stroke, and heart failure. A total of 8133 participants had average blood pressure measurement 14.7 times in 3.28 years in SPRINT and 1094 participants who had average blood pressure measurement 165.4 times in 1.37 years in HK cohort. Quantile clustering assigned one-third participants as high BPV level, but machine learning methods only assigned 10% to 27%. Quantile clustering is the most stable method (stability index: 0.982 in the SPRINT and 0.948 in the HK cohort) with some levels of clustering similarities (Davies-Bouldin Index: 0.752 and 0.764, respectively). K-means clustering is the most stable across the machine learning algorithms (stability index: 0.975 and 0.911, respectively) with the lowest clustering similarities (Davies-Bouldin Index: 0.653 and 0.680, respectively). One out of 7 in the population was classified with high BPV level, who showed to have higher risk of stroke and heart failure. Machine learning methods can improve BPV classification for better prediction of cardiovascular diseases.

Entities:  

Keywords:  heart failure; hypertension; machine learning; personalized risk; stroke

Year:  2020        PMID: 32594794     DOI: 10.1161/HYPERTENSIONAHA.119.14213

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease.

Authors:  Sachin Aryal; Ahmad Alimadadi; Ishan Manandhar; Bina Joe; Xi Cheng
Journal:  Hypertension       Date:  2020-09-10       Impact factor: 10.190

Review 2.  Applications of artificial intelligence for hypertension management.

Authors:  Kelvin Tsoi; Karen Yiu; Helen Lee; Hao-Min Cheng; Tzung-Dau Wang; Jam-Chin Tay; Boon Wee Teo; Yuda Turana; Arieska Ann Soenarta; Guru Prasad Sogunuru; Saulat Siddique; Yook-Chin Chia; Jinho Shin; Chen-Huan Chen; Ji-Guang Wang; Kazuomi Kario
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-02-03       Impact factor: 3.738

3.  Clinical Influencing Factors of Acute Myocardial Infarction Based on Improved Machine Learning.

Authors:  Hongwei Du; Linxing Feng; Yan Xu; Enbo Zhan; Wei Xu
Journal:  J Healthc Eng       Date:  2021-03-27       Impact factor: 2.682

Review 4.  Artificial Intelligence: A Shifting Paradigm in Cardio-Cerebrovascular Medicine.

Authors:  Vida Abedi; Seyed-Mostafa Razavi; Ayesha Khan; Venkatesh Avula; Aparna Tompe; Asma Poursoroush; Alireza Vafaei Sadr; Jiang Li; Ramin Zand
Journal:  J Clin Med       Date:  2021-12-06       Impact factor: 4.241

5.  Machine learning approach identified clusters for patients with low cardiac output syndrome and outcomes after cardiac surgery.

Authors:  Xu Zhao; Bowen Gu; Qiuying Li; Jiaxin Li; Weiwei Zeng; Yagang Li; Yanping Guan; Min Huang; Liming Lei; Guoping Zhong
Journal:  Front Cardiovasc Med       Date:  2022-08-18

6.  Can the Salivary Microbiome Predict Cardiovascular Diseases? Lessons Learned From the Qatari Population.

Authors:  Selvasankar Murugesan; Mohammed Elanbari; Dhinoth Kumar Bangarusamy; Annalisa Terranegra; Souhaila Al Khodor
Journal:  Front Microbiol       Date:  2021-12-10       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.